Maple Grove Tracks Medical Device
“All of this bodes well for the U.S. launch of the drug-eluting stent. Still, pharmaceuticals are unfamiliar ground. To fulfill strict traceability requirements, rather than having two people doing the job of one, each signing off on the other’s work as is frequently done in pharmaceuticals, Maple Grove will track each stent using radio-frequency identification (RFID) technology. The new operation should be near paperless as well. “